Search

Displaying results 9291 - 9300 of 10000 in total
  1. Drug

    Sufugolix

    go.drugbank.com/drugs/DB06494
    Experimental

  2. Drug

    AMGN-0007

    go.drugbank.com/drugs/DB06511
    Experimental

    Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.

  3. Drug

    Ragaglitazar

    go.drugbank.com/drugs/DB06533
    Experimental

  4. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

  5. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  6. Drug

    Fispemifene

    go.drugbank.com/drugs/DB06640
    Investigational

  7. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  8. Drug

    Tallimustine

    go.drugbank.com/drugs/DB15466
    Experimental

    Tallimustine, a benzoyl mustard derivative of distamycin A, is an alkylating agent that binds to the minor groove of DNA. … [A182036,A182039] It's association with severe myelotoxicity lead to the end of its development in favour of α-halogenoacrylamide derivatives such as [brostallicin], which have a favourable cytotoxicity

  9. Drug

    IGN311

    go.drugbank.com/drugs/DB04988
    Experimental

    IGN311 is a humanized monoclonal antibody (mab) against the Lewis Y carbohydrate antigen, a blood-group-related oligosaccharide.

  10. Drug

    Anecortave acetate

    go.drugbank.com/drugs/DB05288
    Investigational

    Anecortave acetate (Retaane) is an analog of cortisol acetate; among the modifications to the steroid are the removal of the 11ß hydroxyl OH group and an addition of a 21-acetate group. … As a result of these modifications, anecortave acetate lacks the typical antiinflammatory and immunosuppressive properties of glucocorticoids.Alcon Inc. is developing and marketing Retaane.